Amarin Corp. Plc (AMRN)
14.00
-0.07
(-0.50%)
USD |
NASDAQ |
Aug 28, 16:00
14.00
0.00 (0.00%)
After-Hours: 20:00
Amarin Free Cash Flow : 15.55M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.55M |
| March 31, 2026 | 25.63M |
| December 31, 2025 | 6.744M |
| September 30, 2025 | -21.82M |
| June 30, 2025 | -11.50M |
| March 31, 2025 | -30.95M |
| December 31, 2024 | -31.03M |
| September 30, 2024 | -18.95M |
| June 30, 2024 | -9.157M |
| March 31, 2024 | 0.8725M |
| December 31, 2023 | 6.395M |
| September 30, 2023 | 6.753M |
| June 30, 2023 | -17.94M |
| March 31, 2023 | -89.37M |
| December 31, 2022 | -180.58M |
| September 30, 2022 | -207.92M |
| June 30, 2022 | -195.19M |
| March 31, 2022 | -146.04M |
| December 31, 2021 | -66.53M |
| September 30, 2021 | -76.95M |
| June 30, 2021 | -61.43M |
| March 31, 2021 | -44.83M |
| December 31, 2020 | -22.17M |
| September 30, 2020 | 7.048M |
| June 30, 2020 | 16.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 30.49M |
| December 31, 2019 | -11.89M |
| September 30, 2019 | -34.67M |
| June 30, 2019 | -83.49M |
| March 31, 2019 | -123.22M |
| December 31, 2018 | -94.60M |
| September 30, 2018 | -64.62M |
| June 30, 2018 | -42.85M |
| March 31, 2018 | -29.75M |
| December 31, 2017 | -33.20M |
| September 30, 2017 | -51.40M |
| June 30, 2017 | -63.55M |
| March 31, 2017 | -61.33M |
| December 31, 2016 | -71.34M |
| September 30, 2016 | -76.07M |
| June 30, 2016 | -80.48M |
| March 31, 2016 | -96.14M |
| December 31, 2015 | -84.64M |
| September 30, 2015 | -72.40M |
| June 30, 2015 | -68.60M |
| March 31, 2015 | -55.41M |
| December 31, 2014 | -72.30M |
| September 30, 2014 | -95.09M |
| June 30, 2014 | -120.84M |
| March 31, 2014 | -161.35M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Neurocrine Biosciences, Inc. | 812.00M |
| Alkermes Plc | 221.65M |
| Cellectis SA | -45.36M |
| Akari Therapeutics Plc | -10.74M |
| Liquidia Corp. | 150.69M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.612M |
| Cash from Investing (Quarterly) | 6.124M |
| Cash from Financing (Quarterly) | -0.2495M |
| Free Cash Flow Per Share (Quarterly) | 0.3176 |
| Free Cash Flow to Equity (Quarterly) | 6.942M |
| Free Cash Flow to Firm (Quarterly) | 6.612M |
| Free Cash Flow Yield | 5.33% |